chevron_leftBack
Medprin Regenerative Medical Technologies Co., Ltd.
301033
56.80CNY
-3%
7.79 USD
As of 24 April 2025, Medprin Regenerative Medical Technologies Co., Ltd. has a market cap of $531.64M USD, ranking #11567 globally and #3642 in China. It ranks #1123 in the Healthcare sector, and #121 in the Medical Devices industry.
Key Stats
Market Cap
$531.64MUSD
3.87B CNY
Enterprise Value
$507.13MUSD
3.7B CNY
Revenue (TTM)
$37.88MUSD
276.03M CNY
EBITDA (TTM)
$14.72MUSD
107.26M CNY
Net Income (TTM)
$9.37MUSD
68.26M CNY
EBITDA Margin
39%
Profit Margin
25%
PE Ratio
56.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Jianhua Wang
open_in_new
Employees
278
Founded
2008
Website
medprin.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3% | 3.3% | 20% | 28% | 24% | 68% |
Upcoming Earnings
Earnings Date
Fri, Apr 25
Tomorrow
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
301033
广州迈普再生医学科技股份有限公司 Class A
ISIN: CNE100004NB8
Shares Out.:
Shares Outstanding:
66.167M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
56.80 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Medprin Regenerative Medical Technologies Co., Ltd.
Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers dura membrane patches, regenerated oxidized cellulose, and craniomaxillofacial repair systems. It also offers ReDura, NeoDura, Recranio, and StypCel for neurosurgery, and 3D bioprinting applications serving patients internationally. Medprin Regenerative Medical Technologies Co., Ltd. was founded in 2008 and is based in Guangzhou, China.
